Good evening everyone and welcome on behalf of Asos marok it is my great to open Pharma forward or second major Conference of the year after weeks of preparation and a lot of anticipation we're finally here ready to dive into conversations with some of the most brilliant voices shaping the future of healthcare and pharmaceuticals but before we begin I want to take a moment to thank all of You for being here your presence is what gives meaning to events like this and we're truly grateful now before introducing our esteemed guests let me reflect on or maybe
remind of what our association as marok is all about Asos marok was created with a B ambition to highlight the richness and potential of our country from every angle from culture to business strategy entrepreneurship and Beyond we strongly believe that Morocco Is a nation On The Rise a dynamic bridge between Africa and the rest of the world full of opportunities and full of potential it is a country that deserves to be both studied and celebrated and who better to do so than those with the ambition to shape it future and to drive meaningful progress it
is with this vision in mind that ashs marok was created to bring together voices ideas and actions through events like this one to inspire And Empower those shaping tomorrow to the mar alumni and Founders in the room we see you and we know the barus set is high but we're committed to carrying this Legacy even further now today we are honored to welcome two remarkable leaders whose work embodies this very vision their contributions to the pharmaceutical and Consulting Industries both in Morocco and internationally have been nothing short of Transformative let me Begin by introducing aanu
chairman and CEO of Cooper Pharma a true Visionary mru has transformed Cooper Pharma from a family business into a global leader in the pharmaceutical industry recognized as one of for's top 100 Healthcare leaders his leadership has paved the way for strategic Partnerships with industry giants like mer fizer and P Pier Fab expanding access to healthcare across Africa his work has firmly positioned Morocco as a key player in global pharmaceutical Innovation mru we're truly honored to have you with us today and we look forward to hearing more about your journey [Music] welcome and now it is
my pleasure to introduce Mishi partner at mckin and Company a graduate of M has played a pivotal role in guiding organizations across French speaking Africa and Beyond through bold transformation his Expertise in healthcare and pharmaceuticals includes advising Cooper Pharma of its strategic expansion into key International markets such as Saudi Arabia the UAE and subsaharan Africa his work continues to strengthen Morocco's role in shaping the future of global Healthcare and we're very lucky to have both the company and the consultant in the same room with us Mishi we are equally excited to hear your inside so
welcome as well Finally and as we begin the only thing I want to add is be curious ask questions and make the most of this opportunity to engage with these leaders so welcome to Fara forward and now I invite you Mr sh to join me on stage you see thank you so much Lena correct yeah exactly yeah so thank you so much welcome uh thank you for welcoming me uh let's have a Very cool relaxed interactive uh session uh please try to make the most of it uh um very informal way uh you need to
take the maximum of it and I am your serve I am your servant so use us and we have some colleagues here anything think you'd like to know we could uh shed some light it's a pleasure so once again thank you so much for the organizers and let us start so I the mic the mic this is the mic okay so uh a quick snapshot on Cooper Pharma Then I think there are some Q&A then we'll go M and I on a kind of business case or the a mission we've developed uh at Cooper Pharma
over Africa and then back again to the room with questions okay so I'll try to go quick to allow more time for uh exchanges and uh communication so to start on on uh Pera it's a very special company that started in 1933 so we are 90 years plus um and uh it's a leader over the region of Africa m East in casablanka uh some figures uh it's $315 million uh revenues uh 1,600 employees um one quarter of them are in sales uh and we have nine manufacturing plants over uh Europe Africa and Middle East and
also in Morocco we have also distribution uh activity that is separate from the Pharma one and this is something that we are leveraging to go somewhere else so just some some Milestones in 9 we were under a business model of export so we were Manufacturing in Morocco then exporting uh in 2013 this is a pivotal uh uh date because we decided to create uh intern National Hub in UAE in Dubai and Dubai is uh where I'm living now for a couple of years is a really uh great spot to be and could be a discussion
if you want to talk about Middle East what's going on at the moment in the Gulf in the GCC Dubai Riyad Saudi Arabia So we decided to go there and there you must bear in mind one thing why people go there beyond the reasons you can think of the main one is access to Talent so you understand already that it's always a story of people uh 2017 we built a Pharma company uh in Dubai called pharmax and it was a JV between a another another Moroccan Pharma company and locals and this company has been very
quickly within one Year EU approved so approved by the European medicine agency and this is as of today the only one that's been approved uh in in the UAE then we we are very long- termist so you've seen 90 years uh so we built for the long run uh so I didn't expect to sell it but what happened is that during the covid uh the local authorities of Abu Dhabi wanted to control uh Pharma manufacturing because it was a strategic asset so we sold to a very big Sovereign Fund even if it was not in
our plan but we are glad to have this uh organization in place in UAE in 2022 uh we started the operations of a plant uh that's the first one in in Rwanda Rwanda is also something we can discuss because it's an amazing country in Africa something you cannot expect you would not expect and it's called the uh Switzerland of Africa it's very different from the images we can have on Africa so I love Africa in general but Ronda is very very special and a dear place to me and a lab and we are just neighboring
kelan University that's the location we took at Kali Innovation City so uh it doesn't seem linear what I've done I should have started before so in two yeah I'm it's like this so what you can see here basically it's a story of organic uh setups and also acquisitions so it started also in Europe in 2000 with the acquisition of a company in pag in praa that is doing Probiotics uh 2015 we we've done something inside 21 that's very interesting what we've done in 2021 we created Cooper bioscience in Dubai was also an office in paloalto
on the at Stanford University uh and this is doing um participating into Innovation but we don't do innovation but we team up with guys like spinoff from MIT from Stanford from uh um uh American hospitals I can talk About this if you want and in 23 we did something important that was the acquisition of sanofi plant in Saudi Arabia so the question is why sopi would sell and if you want to have this question I can go uh dig into it what's going on in this big farma world at the moment uh so we we
we with my colleagues here we acquired 100% of this plant and kept all the sanofi business in Saudi Arabia and this is also opening for us the door to a lot of development our Story in Saudi started 12 years back before that with commercial organization and with this acquisition we are now 200 people almost in Saudi between between manufacturing saves and and and support yeah so here what we are very proud of is that out of the, 1600 people uh we have a great uh gender parity so 49% uh uh uh are ladies and this
has not been done by Design there was not a plan to say okay we need by 2024 to achieve this no it's been made Just by skills by competence so it came like that and this is also uh great to know if you go on the ground You' find other interesting surprising story uh data uh 80% almost 80% of our staff in Saudi plant are women Saudi women so this is something that we might not expect but this is what's happening on the ground and the wien men are in Saudi are great not as great
as the women in Morocco or from Morocco because they need to prove so that's very important It's always a story of drivers what is driving you so in Saudi knowing the situation of women now they are really a very powerful force because they need to prove to the world to the country that they can do so it's great stamina great things happening um and in our uh top management like like 150 people let's say 10% of that uh almost 2/3 are ladies at at Cooper so uh geography wise uh I've Talked about it you have
Morocco that is the the base that is the foundation and still the foundation of course and we owe everything to our country where we have five uh plants either on our own or in JV we have yeah a culture of bringing uh uh Regional leaders to do uh to localize new technologies so uh the number two Indian Pharma company you know that in Pharma uh India is making 30% of the global Supply uh of the world so we have A Partners called sea and we have a JV in rabbat uh with them making uh some
technologies that uh that were not existing and were fully imported before we have also a JV in Morocco in 10 years with the number one Saudi company so we have this culture and by the way uh Cooper is not Cooper is Coop it's derived from Cooper Cooperative in Arabic and cooperation is a transversal in our strategy and DNA Um so yeah North Africa West Africa East Africa Europe with cck and Madrid uh because Madrid is cool uh that's where we basically are yeah that's also very important uh we do business with people with location we
like if there's a super business somewhere we don't like we don't go don't uh Cooper Farm in Morocco yeah nothing special you would not find in our website or gener Information I think if you we are a little bit different from the other guys of the region because we we've been uh more doing things regionally and internationally um we moved from export mindset to localization building a plant in codir building a plant in Randa or in Saudi Arabia is not something easy is not always fun there's no clear payback I mean the payback you expect
from your Excel sheets is not what happens in reality but you make something that is Useful so you make something that has sense so you create so we are not guys driven by the money of course we manage money it's important but we'd like we're we're blessed to do something that we deem useful for our communities for ourselves for our the patient for our population so meaning uh is a very high uh motivation also beyond the figures beyond the recognition Etc uh because you you will see it in your career or maybe you see it
already um uh we need To find sense we need to find meaning we need to find ourselves useful beyond the metrics we are used to uh and we are blessed to to have such uh opportunities to build to contribute humbly to build uh access to health care to localize technology to learn people in Africa in Middle East uh yeah and to contribute so basically I I think that's what we call impact than Mr sh and welcome to s from your Beginnings at scha business School to the classrooms of Stanford Graduate School of Business youve built
a career rooted in Innovation and adaptability starting in skincare and financial services you took a bold step into the pharmaceutical sector in 2000 since then you've LED Cooper Pharma to expand your exports into over 24 countries balancing growth Innovation and impact but tonight we're here to go beyond my stun and numbers tonight is about unpacking how you made it all Happen the decisions the challenges and division how does a leader take a family business and transform it into a global Force how do you position Morocco as a leader in global Healthcare and what does it
take to challenge and expand the limit of an industry that touches millions of lives every days ladies and Gentlemen please join me giving a warm Round of Applause for a so my first question is that you have decided to pursue business studies in Your early in your academic Journey at that time were you already considering a career in the pharmaceutical industry or were you exploring broader opportunities thanks I mean uh no I was not uh looking into Pharma I was I wanted to do my own businesses I'm uh really an entrepreneur in spirit so I
remember that um when uh I was uh um going through some uh all at business school for to get into entry the question was how was giving me was How do you see yourself in 20 years from now and I I see myself managing a lot of businesses so there was a but which ones I I I didn't know and not farma and uh early on um already at the second year of business school I create I start I created two businesses in Morocco commuting between Le and uh and and casablanka um and I think
it's only when I I I put in place with successes with failure some uh businesses on my own that there was an opportunity to go uh Into the family business in Pharma that I join but I had to to to to do things on my own to start some stuff before going into the family thing uh yeah so initially was only entrepreneur ship spirit that I still have and I'm active in other sectors I'm still very curious um and then what happened on the Pharma I was of course uh seeing every day my father building
the Company Brick by Brick and I get inspiration and because he's exceptional guy and then I found this space uh so potentially useful uh and could have an impact in the country and in the region so I said okay let's go but it was not easy after you studies at schema business school you had the chance to pursue and be a Stanford and you often mention how impactful was your strategy class the first day you were attending this class the professor wrote on the Board strategy is execution so can you tell us more about that
moment and how did this idea shape your understanding of the role of a leader I would say in the strategy of a company this is very fun because actually uh I was reading a cat brochure of Stanford many years before and I was like having a fantasy on this University and to make it sure when I managed to get there um on the eve of going there I was like Okay I'm going to California it's going to be fun I'm going to create some businesses from there again in Morocco I'm going to do Sports and
have fun Etc but actually it was I could not do that the the the program I've did is uh the the two years MBA program are for 26 years old guys and then there was a program that is a much smaller class where we do 80% of the program in 10 months so it was horrible uh uh it was too much it was uh crazy and and the First months is uh uh we were doing very difficult classes for me I don't know if you do here re resarch operational manipulating data uh a lot of
of things that are not that fun so after on on the second term when the strategy class was announced for me it was like ah at last I'm going to see the guys from from Nike Google Microsoft and going to hear about this great ideas and stories and the first thing the the Teacher did on the board on we call it in Arabic sabora with tashir with with L was to write strategy is execution so suddenly every dream every concept you dream about is collapsing because this is not strategy I was expecting where is the
fantasy so it was Welcome to the Real World so very very important I mean uh it's like the idea in in French what you say 1% of inspiration and 99 of transpiration it's Really this when you see those great Concepts coming from there I mean we don't see how much failures happened before how how much uh stress how much hard job how much job that can seem like Elementary like with low value added so this is all the story of this and strategy is execution and then on the on the execution you need to do
it super right you cannot you cannot miss yourself you can and it's almost like a military so this is the ideal but in Reality we try we we fail we correct we improve so this is the meaning that uh yeah I can do shorter replies that's perfect so every Co faces defining moments especially at the beginning of their Journey can you share with us the main challenges you encountered when you first stepped into Cooper Pharma and what did this teach you basically about yourself as a leader today yeah I think um um the main challenge
was to convince a Successful company that is existing for a long time uh that we need to change a little bit the business model so it's very very difficult to uh come like this as a son within an organization with the governance and people so you already are coming with a liability because uh and then when you say okay we need to to change because this and this is coming so what so this was the main Challenge and and there was something changing in The Fara so it is difficult because I think people uh who
are very good are taken in what we we study I don't know if you studied this guys is what we call the the competency trap is that you you have a skill in a company and you you try to improve it and improve it and improve it but when there is a shift in Paradigm you don't you don't see it and you are caught in your competency That you think you're improving while or whereas the things are changing so it was very difficult to to explain this I think um so the takeaway here is that
people who are too much into their job uh should what's going on uh in in uh in Morocco or in the region looking at what's going on sometimes we say oh this is not working in our country we are no uh we are really linked mobal setting and VOA yeah okay thanks a lot for your Insight you emphasize the importance of deep listening and a culture of debate but once that achieved you describe Cooper for as approach as executing like a military so how do you create this balance between open dialogue and discipline execution um
I I'll tell you how we do it uh I believe we create an environment when Where debate is allowed um culturally maybe it was not the case uh or not much so but you need to create an environment where debate where opinions different opinions uh are are heard and then we need to take a decision once the decision is taken uh everyone should align even the ones who were debating are not agree and we should align like military for a better execution we come back to thep so to Make it sure that's the answer thank
you in a for interview you mentioned aligning with Morocco's Healthcare reform to achieve 100% coverage by 2025 how is Cooper Pharma overcoming regulatory challenges to ensure timely access to Quality medicines and support this goal so so so first of all when we talk about health care in Morocco uh our King has made great project called the CT Universal coverage by the end of 25 so There's been a massive uh uh mobilization into that at our level we try to cont contribute uh with a increased localization of goods uh you must know that uh in in
Morocco almost 2/3 of the medicine we are consuming are locally made whereas if you go to France it's less than 60% or Germany less than 60% so contributing to the localization local manufacturing of farma Technologies what the Pharma environment and players and we have 52 players are Contributing very well and remember in covid it was essential because the lucky ones were the ones who had access locally to their medicine and alhamdulillah thanks to God and our efforts during covid Morocco was quite well organized because you had this uh access so that's our way to contribute
so Africa's pharmaceutical Market is heavily reliant on import with up to 94% of medicines coming from outside of the continent how is Cooper working to Strengthen local production or to ensure accessibility and affordability for medicines in this continent yeah so so first of all uh I was very mad against all what we heard from the big farmer many years saying you cannot do this technology in your countries you cannot do this is taken for us this is happening on in Europe and us and Japan no and this is exactly what is happen happened in Africa
can you imagine uh 84 or 9% Reliance on report for things that can be locally done this is outrageous so you must know that was a big thing the the the guy who have technology want to keep it and would always tell you not possible complicated Etc so you must we should not be naive of that so once you say okay what are we talking about so for me we should contribute to have at least one two plenty in every African country to do paracetamol amoxicilline the Basics and you hear about Pharma with biotech cellen
gen therapy super stuff incredible stuff crisper technology but 20% of drugs can cure 80% of disease and this 20% are low Tech so for me I'm outraged when I see these kind of things no this is not for you guys you're in Africa no no way so we try to contribute as many other players from Morocco and from the region to build plants and for in Randa in Coto maybe in other Countries that's our way um and even here in France it's not normal guys you were this country was one of the best in in
in chemicals ET so I'm not criticizing to criticize but I'm saying industry manufacturing is essential we should keep some stuff in in our case in Morocco our King also has done a great initiative is to build 26 hectares uh plot of land vaccines if you D dig into it you would Say it's not easy to sustain a vaccines plant because vaccines are follow pandemics and vaccine consumption is not always linear and you need to keep up with a plant that is running every day still this is strategy so so so we need to have this
we need to to to so even here you need to get back some of the local manufacturing of Pharma you need to get back how uh the active ingredients and should not be kept only outside of Course when you do the economics when you compare there are countries that have higher economies of scale where it makes more sense to do this okay this is maybe 80% of my Supply then I can afford 20% local or in the region of Europe or in the region of mediterrania so this is the kind of stuff that we should
also and the problem uh that uh guys have in Europe is that you're you're governed by short governments five years so you cannot Pharma is longterm so you see there is also politics involved Etc um yeah I don't know if I answered your your question but this was my outcry you mentioned earlier in the presentation I did not scaling rly across continents and countries it can come with significant pressures both personally and professionally so how do you manage the demands of leading coer form at such a Scale and would you say that there are any
values or support system that help you maintain resilience I did I did not get the the question so sorry yeah so scaling across countries and continent can come with pressure yeah so it implies that you're leading Cooper farma at an important year scale so how do you manage the these demands of working in so many countries and continents and the pressure that can come with it and would you say that there are values or support System that help you maintain resilience make it sure I don't manage no I'm kidding um first it's a super motivation
that guys from Morocco are going in the region are going more globally so we are the ones and we are not only the only one in far Pharma we are not the only one in it's not the only sector so we are going to places where we are not supposed to go where we are not supposed to be seen This I like to surprise and also my message here is to tell you that there of course there are limits but there are no limits I mean the limits we put to ourselves are are in our
mental I'm not saying we're going to Mars of course we need to be realistic so we should be decomplexed DEC complexing so this is a point so first of all there is a motivation then guys like you and guys from other business schools from School of Engineering have Having are having access to the same education that guys who are working in Europe or us and some of you are coming back to your countries in Africa so and the most important thing is the people the most important thing and we are blessed in Morocco we have
a nice environment Pro business so we can take it then comes the question the country does have does the country have the comparative advantages like the um Porter forces Etc So big motivation it's possible to go beyond our usual uh boundaries and then managing complexity outside it's a big equilibrist uh play because because you're managing first of all different cultures so you need to have a mindset of agility a mindset of accepting the other a mindset of not saying the I have the truth to be open but still you are very well in your feet
you are very aligned with your mission and Values and then you you and then you you you and then you you try to swim that that's it so many C speaks about kpis and financial Market but you draw from philosophy literature and spirituality to guide your decision so my question is what philosophical principles or spiritual lesson do you find most useful when you're faced with difficult decision in the boardroom make no mistake we're we're Handling businesses so kpis Finance strategy called figures called things reporting systems governance is essential maybe uh I do believe that uh
we can be nurtured by other Industries the cost fertilization things then on the philosophy think uh try to answer I don't know I mean but for me philosophy is really the higher uh level uh when you remember when we were in uh you were maybe in baloria we Were studying philosophy at that time I don't know if it has changed or not there were 20 chapters and uh mathematics and logic are part of philosophy and unfortunately in our culture philosophy is down graded we say fif it's negative whereas it is the most essential thing so
yeah but it's going to be take us to a lot of things so yes and then you touched on spirituality on of course I mean we're not machines we want to Know why we're here um why we do that so you're taking into and it's always a higher of view Etc so I try to reply as I can H last but not least you have an impressive career both as a CEO and as a leader in the pharmaceutical industry that's really impressive and inspiring for all of us tonight in the room we have very diverse
backgrounds business engineering but also medicine Pharmacy And biology what advice would you give to the students who aspire to follow a similar path to yours first of all I can share my experience in Morocco uh so in Africa in Morocco I mean um uh it's moving a lot we are doing great plans uh we had your president couple of weeks ago couple of days ago we had xiin ping so there is something happening uh And it happened for a long while so it's an exciting place to be to build business to contribute to what the
nation is doing and it's been already done but we have our contribution and I'm I'm glad to with my friends and team to to to contribute to that in terms of Lifestyle I've been living here in the US in the Middle East Morocco is unique um so what I can tell You is first of all to follow your convictions to for your your dreams to listen to yourself don't listen much to the the Verity Grand prophecy listen to yourself I think the most um the most important thing uh where I spend a lot of time
was listening to people instead of listening to myself so have confidence and follow your dream we have one life under Earth I don't know if I'm replying again to your question so you need to be Decomplexed everything is cool don't be overstressed if you feel something go for it whether it's musical whether it's Arts whether it's fintech what just go for it because what happens is we are into Excellence when we are aligned and it can take a life to align yourself it's not easy so um uh yeah try to listen to your inner Voice
uh sometimes when I have difficult decisions I and you have a lot of Matrix we know we receive reports we hear advisors we to take but at the end you need to take a decision so just close my eyes and say Okay let's listen to what saying so this and and and be curious that's the the the the the science going on the Innovations going on the access to information you you guys have today wow I mean you need to eat that of course you should not get sunk I mean But but there's so much
stuff and do it your way don't for because at the end when you'll be uh interviewed and recruited by a company or if you want to go to another higher education uh organization they want to know your uniqueness your difference because a lot of guys are doing the same schools than you guys but so so where is the difference is in being true because when you're true you're you and everyone is unique say that's what I would say so Perfect thank you very much Mr shlu for this first part of the presentation so now we
can move on to the second part and I invite Mr medilish on stage to give us some insight about this fantastic industry and the future of it thank you very much so so Mei is my partner in crime must tell you if I if you may I'd like to talk you start telling uh stuff about me I'll tell stuff about you so just a warning It has been very polite and so on the Troublemaker is coming no uh McKenzie BCG Bane all those guys you see great companies but I would like to tell you one
in in in 10 seconds the the value you build as a company or as a CEO or a manager like me with strategy and organization companies like the one of Mahi is not just the brand McKenzie it's The person so it boils down again and again to relationship with people science Insight super ideas are nothing if there is no trust so we come back a lot to Basics to Human things and what is great in his house in at McKenzie is that they really go with their clients who are actually partner not in a commercial
spirit I mean it's we have had so many workshops discussions that did not end with Mission and billing Etc so This is of maybe also what I can share uh of my experience uh with Medi he who is still my partner in crime thank you thank you appreciate so since you you've been very very kind to me am I allowed to to say some nice things about you okay great um well I mean let's let let's put down the phones for a for a minute I mean this is a secret I'm going to share I
don't want it shared elsewhere amen here is my preferred client [Applause] because we always have fun actually it's always we always have fun thank you very much for for trusting me uh so I I was asked to uh to say a word or two about the the future of Pharma some of you saw the chart earlier it was disclosed uh I think I'll I'll I'll I'll keep it I'll keep it very short because I know some of you here are are in science have uh pursuing double degrees and so on so you Probably know uh
all of these things this is at least the way uh I mean most people think about it I would say I mean nothing uh rocket science if I'm allowed I think there are uh there are three layers right the first layer that you see is basically the science in itself the second layer is is more the en environments of of of Life Sciences and and biofarma and then the third one is probably the the uh the expansion or the the connections with the with the with The with other sectors and domains so on the first
one I think here there are a couple of examples here I think uh uh Aman mentioned crisper Jen editing uh synthetic biology and so on all of these are what is what it is doing at the moment is it is we're entering an era of massive personalization of uh treatments basically right that's that that's what is happening it has been happening actually for years it's no news for uh for the scientist in uh in in rooms and This will continue to accelerate probably with a with with an effect with a Dem multiplying effect if I'm
allowed from uh uh from from Tech technology in the sense of uh analytics and even artificial intelligence right so more and more we would be as human beings allowed to have personalized treatments this has massive implications on on the way we we actually organize the the the health systems and and even the way we uh the way we live right that's we Because we will have to pay for them right if if to today you tell any one in the pharmaceutical industry right you are going to you're are going to manufacture products for one person
right that that does not make sense there is no business case for that if you tell that to a payer to a health system and so on so we we're still we're yet to invent or reinvent a way that uh that that can sustain this evolution of of Science and uh and and Innovation Then there is the second layer which I feel sometimes we um we take for granted and we uh we we we we we Ender we underestimate which is the environment so the environment of of of of of Pharma right so first of
all think the way the care the health care will be provided or is being provided is will be less and less uh in person right many things can be done uh remotely which uh will uh push Pharma and life science players to also adapt uh there are there is a new Generation of uh of Physicians who are digital native and who would want uh to have discussions regarding treatments uh not in the traditional way of uh of detailing which was sending you know uh human beings to talk about uh uh about about the drugs and
leaving some goodies or some in ations to some uh to some Congress this will have to be reinvented in this new world where even them as Physicians are actually uh providing their services more and more uh Remotely also mentioned before I think the the domain of uh of of diagnostic will uh will change quite a bit is already changing with with AI uh so that's uh that's uh that's also in terms of how to understand uh patients physicians in their interactions and so on and how Pharma and Life Sciences in general understands this uh evolving
relationship will be will be very important and maybe can if we are entering connected to the first Layer into an era of personalized uh medicines you know maybe life science players could play a a bit of a role uh in enabling uh also um uh also uh the uh the Diagnostics linked to uh to personalized uh treatment uh leveraging uh leveraging technology and artificial intelligence viable design devices and iots and so on is already is already given and um and and the last part is uh is uh is more and more uh focus on sustainability
Climate change so on the one hand science I'll connect to the to the third layer is is actually contributed contributing to uh to that agenda but uh the life science and especially the manufacturing part of uh of Pharma uh will have to contribute its fair share to car to carbon batment right so so far you know if I oversimplify we've basically sent uh all the D manufacturing to emerging countries right now that Europe wants to Relocalize they understand that this has also some uh impact on the environment right so it's a different discussion but probably
you know there needs here again to be some uh some reinvention and again some reinvention through uh Innovation and then the last the last layer is on uh the expansion right um more and more the common belief is that um life science biotechnology and then basically technology information I mean uh it Digital analytics and so on uh will uh will get closer uh to uh to serve greater Goods greater good uh on the one hand of course you know treating people and Improv proving or increasing life expectancy is already what's happening more and more it's
about quality of life right so it's it's but there is more and more a common belief that uh there could be the evolution of science could could have Impact uh in in in in broader domains so on on food systems for example right on on broader agriculture right on everything that gets into a human body right uh to that combined with uh the pressure to uh uh to aate carbon and uh and um and face the the climate change uh imperative is also an interesting Trend to to take into account when we talk about about
life science so you know that's the that's what we are talking about when we're talking future Of Pharma I was asked also to uh maybe give a flavor of uh what is it uh to work uh with the with the with a client and with a client like like coper so decided together with the with uh Amen to uh to tell you about what uh when we've been thinking about uh development in uh uh in the rest of Africa outside of Morocco I mean that's a that's came at a moment where Rwanda and C was
were were already well uh well Underway so the discussion was about what else how do how do we work uh how do we work together right this is what you see in terms of uh in terms of context I wanted to show you just um and maybe we'll let uh Amon comment uh just some of uh the approach I went too far that's the context so we missed one no big deal okay um the I had another slide About uh and maybe I forgot to uh include it about how how do we work together what
are the principles of uh of a trust based uh relationship basically we're looking at um at four components uh so obviously geography uh is Africa theraputic areas were were actually it was it was actually open so we try to uh uh we try to look at the Dynamics uh for uh large molecu for for large molecules for vaccines for OTC Over the cter for so every type of uh of um of uh of products then we try to look uh at market segments uh customers and uh and channels uh so depending on the geography and
depending on the the therapeutic areas the way uh to reach the final uh the final patient can be very different so private retail is one public institutions is another uh the structure of uh Last Mile distribution and Retail distribution can be can be different in each one of the countries And for each one of the category products and so on and then depending on all of that and the starting point and so on we've been looking at uh ways to uh to enter the market uh between the organic and inorganic between what uh should be
local manufacturing versus experts and so on so forth and this is you know multi-dimensional we have to to cross all of the all together at the end of the day it has to make sense for what coper wants to do but it has also to Make a business sense so in in a in a way where we've put um we we we we we we we can uh have an investment return investment profile that would be attractive uh to any type of uh uh investor and I guess not see poor thank you uh yes thank
you very much uh so that's uh that's what uh That's how we've been uh thinking about it the first thing uh that we we've done is uh is doing this situ situational analysis which is assessing the the commercial potential at an aggregated level for the continent and then for the different type of uh Geographic uh clusters so that includes uh microeconomics regulatory aspects and then we crossed the the dimensions I uh I I described before which was the therapeutic areas the product categories Then the channels uh and so on to see where are the pools
of uh potential for what Cooper was uh was trying to uh or is trying to achieve right based on that uh we had several workshops to basically decide on the way to play so not only geography but also Mark uh but also um product categories and then and then uh and then channels and some products uh uh Cooper would have and some others they they they won't have so that triggered other conversations about are There uh uh business developments uh that should be uh that should be triggered uh or some Acquisitions and so on at
um at portfolio level and or at geography level and only then when we had prioritized the way to play we had U uh we had a couple of weeks on on the how to win which is assessing the the Strategic go to market that is then depending on the previous assessments um whether Cooper would go there organically or inorganically also What time sequence and so on the last part is a is a bit of the synthesis both putting the numbers together so how does it look like from a financial uh uh and Commercial perspective and
how does it look like uh from an operational perspective what to do when What teams do we need how do we uh have the right balance between the existing teams in uh in coper and teams that we could be recruiting uh from elsewhere or Integrating through Acquisitions and uh and so on that's basically what we ended up uh doing and uh most importantly we created something that I think and you tell us amen was a bit of of a compass or or an or Star which we which we call the the equity story which basically
was a description of this is the plan uh that we would want to pursue we know that uh you know the situation in in Africa can be Volatile uh that many of the developments have to be in organic and there are not always uh good deals available so since then we have been looking at a couple of deals together the Cooper team has been also looking by themselves and what I think uh you know this exercise uh have served is is to create a bit of a backbone for what they want to do versus what
uh seems to be a distraction both from a management perspective and a financial uh uh Perspective but always with the uh bigger mission in mind or bigger purpose in mind which is that coper stands for providing affordable African uh made uh or locally made uh treatments uh to uh patients in this geography that is Middle Eastern Africa and this circumstance Africa so that's uh in a nutshell what we ended up uh doing very [Applause] Concretely I I would I don't know how is the format but let's just go with the flow um I would build
on what you just said like a guide book on what is the strategy uh 20 years back with when I started with my friend who's Phan respons direct she told me am man strategy is what we will not do so it's very important also to Define your scope strategy is also what we will not do and By the way it was very difficult for me because I want to do a lot of stuff but you need to have guiding uh things and it's like decision decision I don't know if guys have made Latin class here
okay so decision is coming from K meaning cut copy so to decide is to decide what you will not do that's something that cannot seem very evident but that you okay so you need to to know what you will not do in order to Do good what you'll decide to do questions insults Inspirations thank you hi thanks uh both for the presentation um in my previous life uh I was a life sciences lawyer and I knew I could see how uh important was the relationship between companies and government authorities in terms of fast tracking Drug
approvals and well all that kind of stuff and I wanted to ask any of you if you could tell us in terms of interactions with The Regulators what do you think the differences are between uh you AE and Saudi Arabia currently and our Regulators in Morocco or in Africa or between UAE and Saudi between the both both of them yeah I mean how um you AE treat uh pharmaceutical companies like how is the Relationship yeah and the same with Saudi Arabia are there more prone to be collaborative or very good question so so you're you're
following a low degree I your words super so you you know already that guys I mean today uh law business law is everywhere so if I can encourage you to dig a little bit more into law that's a very useful tool uh today among the the CEOs in Pharma of the largest companies some are lawyers okay so to your question it's a Very good one and I'll tell you my share with you my experience in UAE and in KSA in Saudi Arabia uh UAE I discovered 12 years ago it was really wow because they were
so welcoming please come you want to do localization you want to build plants Etc do thing and they really open the doors like I never seen before uh so uh the regulator very open as long as you're serious in Your long-term investment because they've been also in this region of the world excuse me bullshitted for so many guys who said okay we'll come we'll do Etc or big farmer yeah we'll uh export finished product then I promise we'll localize and they don't do so when you really commit to your word and you contribute in the
economy locally they really open the door and UAE uh it's called moap Ministry of Health now it's an agency is among the top uh there is a Special specificity in UAE also Ministry of Health is that they are the one who want to show to the world that they are the second country in the world to get the latest Technologies so if you see the latest Pharma medicine First Market is uh us and then very often they they take it at in UAE so they are the ones who are fast tracking up to 15 days
it's crazy so they can have Fast Track registration up to 15 days when do okay so this is one Saudi Arabia another Story I'm spending a lot of time there uh I've been really impressed by the maturity by the you have done good job guys like you in Saudi uh in the uh not only Ministry of Health no because Saudi Arabia system of healthare is more complex uh so you have uh the Saudi FDA the Ministry of Health you have the ministry of local content local content Ministry you have theayer so in Saudi you need
to go through a different it's an ecosystem And you and they want to see the boss so you cannot send your team I I I pay myself and I enjoy it you cannot say okay I'll send my team no no you need to go I I took my family and lived there three years in UAE and Saudi committing so they want to see so and there I was surprised by the level of process that they have organized once again if you are serious in Long your long-term invest uh investment so quite surprising and Interesting what
you see in Saudi Arabia and processes very well done now in reality when you go to sh but at higher level in ministries it's it's going very well but it's okay it's okay we know how to handle we're Moroccan here it's okay so I first of all thank you for your insights my name is I'm a student at University Muhammad po Technic in Rabat and at shpo here in Paris so I have two Questions uh for mru in his latest speech marking the 49th anniversary of the green March his majesty the king Muhammad 6 stressed
the importance of the Moran diaspora in the country's development in addition I noticed that the word Innovation came up several times in your presentation so my question is what initiatives is Cooper Pharma putting in place or planning to develop to support innovation in healthcare and health Tech Within the Moroccan diaspora and my second question is as short as it is how did sanui decided like decide to sell you its plant in Saudi Arabia thank you I mean no sorry smile super smile thank you for the question uh first question I've been in this journey quite
bluffed by the great diaspora Moroccan diaspora in the world and we have advisors from spanning from UC Irvine University of California who's a guy working on universal covid vaccine Universal vac Universal po who's nominated in the Nobel award it's crazy he's a super guy to another guy from and this guy Professor Muhammed is from zura to a guy at Thea Institute you know the Carolin ska Institute of course in Sweden from wda another great guy to a guy in in in U In top German University not to name in France Moroccan guys of the diaspora
senes at s Louis so and then I forgot a lot uh guys at Harvard also so I said wow we have such a diverse and super prospering uh diaspora uh and they have one thing would like to contribute and give good back to our country and that's superb that's super here we talk here we talk So through this Cooper bioscience initiative and Company in Dubai and having a branch a small branch in Palo Alto we're doing stuff we're doing stuff we're not not in venting I'm a business guy we don't we're not scientist but we
try to team up with MIT with Stanford with kolinska all things sometimes samsh other times it doesn't work but overall good we've done some great things on the crisper so uh that's so yes yes we have a super diaspora we have guys who are Thriving and if you would tell me I would say how can I transform my company uh to be uh an environment where those great minds whether they are from Morocco or not where Talent can come contribute in Morocco and Blossom and make business out of it also another important point that I've
learned and we're doing with the guys like from private Equity you need to share you need to share you need to make a business models you Know you know those guys in private Equity you raise money then you invest in companies and then you get a fee on the pl value you know those things anyway now no models is to share the value with the talent so some guys came back and they had disappointing experiences in Morocco because this of that that's okay but Morocco is changing and we have environment that is more prone into
that so uh this was your first question the Second question I will not answer no how did we get the son of f deal was competition now we are into a deal acquisition More Than This previous one where we are 20 competitors so at the end of the day uh the short answer is money but there is more to it because God like sopi for instance and I'm not throwing flowers to them so you have big houses and very much in Europe especially in France who Are caring about the ones who will take over their
operations who who are caring about the ones who will take over their people and I found that superb and a great news in this world of business finance transaction and very transactional so they need to find a partner who would sustain their legit their legacy who take care of the people and I found it super because I don't find it in the Anglo-Saxon word always here the care in France with a company like sopi and not into advertising sop I'm sharing my experience the the in the agreements the number of provisions to to take care
of their staff that we are taking over were really important and they've been following post deal so I think uh uh they liked us because of this uh sensitivity and also because uh of what we were doing in the region that was coinciding what was their strategos of changing their model from owning assets To keeping assets locally but owned by others serving them to to make it short uh and I think we won because we have a ladies power at Cooper that is exceptional hello yeah thank you so much I'm going to stand um so
first thank you so much for this presentation and thank you so much ashal for this incredible um event I am Muhammad bahad from Central um so I have basically two qu Questions for both of you guys my first question is regarding the pharmaceutical industry in Morocco what are the the real challenges is it more of a supplier CH raw material supply challenge manufacturing challenge or is it a being cost competitive in comparison to foreign suppliers that's my first question um my second question is I believe Pharma industry is like very Capital intensive with a very
high working capital requirements so the Future of Pharma can only be shaped with like big um players like yours so what the what's the future of Pharma industry in Morocco thank you okay uh then you tell then you tell me then you tell me if uh if you agree or not but actually I think the second my personal belief uh is not to be quoted outside uh is uh that your second question is actually answering the first one uh I think and many people know it I I I I mean if you look at it
uh from a structure of the industry uh in Morocco the there needs to be a bit of consolidation so that the best ones the well structured ones uh the ones that are also more compliant in terms of uh regulatory in terms of quality in terms of uh uh just professionalism can indeed acquire the necessary scale uh to Emerge uh to uh go beyond uh borders so beyond Morocco and also to uh to innovate so the today there is still I mean they they know they heard it from me before uh I feel there is a
there is still compared to the depth of uh of the market uh too much uh fragmentation and different players are are playing with different rules I'm hoping that uh with the new uh the new construct there will be an even additional push for consolidation that I can say you Probably cannot say publicly listen you you pointed out I I fully agree uh fully agreed you pointed that also to uh comparative advantage or cost compe itiveness so if you hear outside you say oh yeah in Morocco in Africa there must be cost competitive but you must
always go to the next question you must okay give me the figures let me see by myself the cost of a drug overall M menos 50% is The activ raw material active ingredient 50% 25% labor 25% amortization so the factor we are supposed to have in Morocco is maybe the labor that we don't have API it's the same price we will buy at the same price 50% of what will do my Cox and probably more because we're small Market even Africa small even Africa Middle East Africa Middle East is for 5% of Global Market just
that's It $50 billion out of one one trillion plus so we would buy as Moroccans at a higher price than a Chinese or a European would buy D Deja already we don't play in this 50% then amortization we buy the same machineries so I have the same cck so we are not don't quot me also we are not price competitive people would sit and say yeah we do export and we would go into the news and say wait we do export we export to Africa your question should be How much do you export you should
be I'm doing the critical analy the critical thinking go beyond what they serve you what you read 8% of our output we export to Africa a Mal because we speak the French I'll tell you the truth because we speak the same language but I'm fight we're fighting with Chinese with Indians who are much better in cogs still shall we die no way so what Do we have what do we have we have a Kno how we know the Norms we know how to build the plant we know how to run doctors scientific information sharing ET
so on a we have a a think that we should not export only our Goods because it will be limited we cannot buy by definition by cogs by economies of scale but we can export our Capital our skills and do these plants these Pharma companies abroad this is one Avenue but you need to have the mindset of that it's not easy the problem is the mind mindset of the players and the second thing we can also learn we can start okay to establish ourself in Innovative centers and learn we should not dream like crazy we
should dream and do things that are realistic they're still stretching to to reply shortly because that's a great question but of course consolidation is needed in our sector in Morocco in other Sectors in Morocco but we're facing ego yeah that's another story because when you are in family setups people are have their own egoo it's not so it takes time and then it's a matter of generation Etc so this is the reality of and also the beauty of entrepreneurial entrepreneurial family business because the family businesses in Morocco like in Africa are driving a lot the
economy but there are also limits to go To the next wave that is calling for consolidation for bringing professionals and no longer guys from the capital so it's a it's a it's another it's a process and we are into it uh recently last two three years the mar sector is starting to consolidate with what not naturally within its player its players they did not manage with the entry of the Pees private Equity they are the good consolidators uh hello thank you very Much for your presentation I have one question for both of you so um
if I understand well there is Cooper has two streams the first one is GMC manufacturing and the second one is fabricating under license and as Mr said we see some Trends in PH in the pharmaceutical sector where we are going to focus more on the individualization of uh of of medicines uh and maybe on other Technologies like gen therapy uh the Question is how do you see the the future of uh of first of all your first business unit uh in this context knowing that there is some big guys that for example fer is focusing
on biotechnology or sopi that sold its uh consumer Healthcare division so they are going on this trend of individualization high high development maybe do you think that you in Morocco we can have some research even if it lasts uh 20 years to develop a drug but if we can have some uh Research to to fabricate drugs in Morocco or in Africa and if know what what do you miss uh to to have this thank you so uh great uh great questions tonight great audience for that exactly but you you you you started saying that everything
I do is free so that's it was not a with Okay good fine great um listen I think for Middle East Africa For emerging world the trend that uh that you picked um and for players from the emerging world is will actually I mean is actually an opportunity before becoming a threat uh and you know if I was asked why uh coper bought back from uh from sopi right I think it's it's it's following the same the same Trend right I mean big Pharma as you said fizer and so on they have You know constraint
funds that the basically Global markets are dictating to um to earmark for uh Innovation which is harder and harder to uh to uh to Define right if you think about it where the markets are which is developed uh developed countries right we're reaching I mean 90 years of life expectancy and then even if you do like uh anyone in in a good uh in a good business school some even you know more Granular segmentation actually the people who can afford to pay premiums right they actually the the their kids the ones that are uh they
are born today have act have actual life expectancies that are probably Beyond a 100 years right so in that context defining an economic model for the traditional Pharma that was all about uh improving or increasing life expectancy and then quality of life I mean it's it's harder and harder and Think about how much people are now and systems are now paying for extending the life uh of of someone for three months four months five months in in average right so so so re reaching a little bit of a of of a limit the emerging worlds
which are billions of PE of people right still the vast majority of uh of uh of the world is not at that stage at all is not at that stage at all right so this is creating an Opportunity uh for private money not not public uh including family owned businesses that are modernizing it's creating also an opportunity uh for players from uh from the local um from from the from the emerging world so that's why there are more and more deals uh that are of you know mature portfolios uh divestments from emerging Emerging Market I
mean if you think about it in the con in in in in emerging in Emerging Market Saudi is not uh is Not small it's a it's it's it's a massive it's a massive market right so that is creating an opportunity but again as U Aman was saying uh more often than not those are pees that are jumping on it right and they are transforming that opportunity into into money that's why it's it's important to have players from all over you have some in latam you have some in Southeast Asia you have some in in the
Middle Eastern Africa they are able to to fulfill that Gap for Now and the hope is that while fulfilling that Gap they'll create enough scale for them to think about the Innovation that are needed in the emerging economies uh when the they will be they will be needed right so I mean that was a bit of a complex answer to a simple question uh yes hi uh first thank you both for your presentation um my name is ma Brahim I'm from the MBA program and I also come from my own uh pharmaceutical Family business in
Egypt yeah we don't talk to NBA sorry should I pass the mic then thank thank you I just have um two questions a question on a followup uh based on your experience and the methods you've used for entering um International markets what was in your opinion the best method for the European market and the Saudi market and the follow-up question is that if you then are looking for Partners what is the criteria you look for in the partners um you tend to then have uh the that deals with so thank you thank you so much
so you your family is in Pharma in Egypt yes J super for first of all I love Egypt it's such a great country great people I think we've been three three times last year thank you I have very good friend in Pharma in Egypt um and people who don't know Egypt should go to Egypt there is this popular genius in Egypt so only that and and Music I love music Arabic music only that is enough for Market entry in Egypt so we are looking to Egypt definitely now your question so you are blessed to come
from this country never forget it and it's a country we love and it's very important if you want to do business somewhere maybe I I can name another or 10 others countries from the regulated market much bigger than Egypt or Morocco or Saudi but I don't feel connected to that So we have the luxury also to decide where we want to go sometimes it's not always very very okay so uh what are the criteria for Market entry to choose a market and to choose a partner that was the question so first of all you need
to map where you want to go where you can go this is what we've done together we've be doing that very scholarly sometimes you say oh this is obvious no go through all the obvious Question the rational behind anything and sometimes we are surprised so don't go quick just do the things very scholarly as we've done we've been through 52 or 54 countries in Africa we came to obvious conclusions but we are convinced of them and Egypt is part of it and if you look at Egypt guys you said why you not going to go
there currency problems local but it's super believe me but it's not easy so okay so you map first of all You need to know where you want to go it's not it's it needs to fall follow a strategy a logic then I think there should be a lot of humility because I've been seeing so many guys companies coming to markets with we know we have the technology we're going to teach you no we need to come with humility when we go to Rwanda to C Divo to Saudi to Czech to Spain we are invited we
are guests so you need to Understand that you need to Bow and pay respect and understand the local markets the Dynamics it is very important ideally I like Partners I like to do with Partners so H Saudi we did not buy 100% of sanofi overnight we had a a journey of 12 Years first thing was JV with pimo number one Pharma player we've been minority just listening and going through the things then we did our commercial operations we had eight guys Now we have 65 in sales and it's been stepbystep so this is our way
so we like to do with Partners that's the way we choose our mode of entry and once we we we we understand the market then we eat the partner I'm kidding no you do step by step so that's my advice what else can I tell you uh then you have matrixes of course of complexity uh payoffs uh yeah so Saudi maybe the the question Was Saudi I I think there's a a lot of sense of Egyptian to go into Saudi it's very much uh so both for Saudi and Europe Europe no complicated there is a
mistake so people will look at so what Mei was saying is that we have a playoff in emerging market that now maybe is even Freer because of big Pharma are refocusing on higher technology that only uh big rich countries can afford so they are not divesting or changing their presence in Emerging market so this is the leaving the place for GU guys like us more open it's never it's never that easy but think about it so we want to go to Europe because of our complex to go that's my assumption to the previous colonizador you've
been sing Tata buying Jaguar you've been seeing Land Rover you seeing another I love India I go a lot to India uh what's this brand in liquers lior uh uh king fisher who've been to India by The way so nobody's perfect my friend but shame of you guys who have not been in India how can you it's I'm I'm I'm Maharashtra I'm not my second home is the Mumbai area so so guys you have not been in India you have not been in who has been in China a little bit more so tomorrow next holiday
you go to India you go to China and you learn China is top India I love it it's Different so but why were we talking about India she king fisher king fish you know you know V Mala okay so same the both Indian European English things so I think there is also a kind of egoistic driver this you will not read uh you will not learn at as or even at HBS but we did a lot of studies at Stanford on the ego of the boss and a lot of things are driven by ego believe
me uh anyway um Europe is difficult Europe uh is mature Market uh of of course it's cool to say I am in Europe believe me I paid the price to be in Europe was not easy now it's okay because the competition is so big don't see Europe as a Pie as a larger P than Emerging Market when there is something larger make no mistake there is much fiercer competition then if we want to go into the details the business model of Pharma in emerging market India Morocco Saudi Lam super southeast Asia go to Indonesia Guys
go to Malaysia go to Singapore super super super uh is different than the business model of Pharma uh in Europe in Us in UK basically branded generics model commodity generics model different payers so I don't want to get into more details it it's not sexy to go to Europe believe me you see it's raining today you know so no so watch out you need to dig there could be Niche there could be opportunities when you'll be under the Radar where you have an angle for sure but look at generics in France everyone is bleeding money
even bogar I think was sold was in the so uh uh Europe is not in the generics business sorry in Innovation if you want to invest in R&D centers that could be cool but but do go do them in in in sudu near Shanghai it's better uh or in Inon in uh so um go dig more it's not always as glitter as it can seem uh do you think Like the food is good in Paris of course uh I think my opinion is that uh since the Cog in Egypt is definitely much less than in
Europe so there is always a competitive advantage in the terms of like the generics we would export would be much much much cheaper compared to Here My Dear uh uh building a business model on cost competitiveness is not great because there will be always someone who will be more competitive than you in Cox That's the problem that's the problem you should not sell only this you should look for something more that will create more differentiation there will be always a guy you're right in Egypt are maybe the lowest on the region if your business model
is to export uh generics and a certain differen shate but I think there is more value in Egypt greatness of people and farm industry to build on other stuff because the the the cogs uh the Cog Competition we taken by uh China and India uh we can play as long as they are not yet there but once they be there that no thank you uh thank you uh I have a one one uh I would like to thank you both of you for sharing your experience um thank you as too my question is really simple
my name is Leila I'm a pharmacy student and I'm in um a health marketing master degree uh I Would like to know what it takes to work in pharmaceutical industry in Africa do you have an opinion about this uh how can I adapt myself because I I've never lived in Morocco or in Africa uh for example to work in medical Affairs in marketing I'm specialized in medical education so in medical Affairs what what does it take to to be pharmacist in pharmaceutical industry thank you it takes a lot of talent I mean welcome welcome I
think It's U probably yeah we have you have 52 Pharma companies in Morocco you have a I think a total of 400 Pharma companies in Africa and maybe easily 50 to 16 midle East to you have a lot and function number one is regulatory uh you're into this you want sorry oh sorry thank you no no of course medical of medical a Regulatory Affairs medical Affairs is is essential so you Will find Opportunities I think at at uh in every company um and we would probably also learn from your insights and your experience so yes
we we need in in Morocco in Africa we need people who have been trained like you we have already we have also people educated in in Morocco very well but we need these guys from Pharmacy medicine seen Business Schools engineering engineering a lot so no problem our head of regulatory and Medical Affair is here first don't be afraid of Africa East don't really be afraid like uh these countries are very interesting to work in first because the decision Center is at the end of the corridor so when you work with companies like ours uh you
can you you have a journey and you are part of the transformation that the company is going through and this is something very interesting and very important for you guys like where you Are not a number in a hierarchy you can make things happen at your level and you can make things that count then when it comes to medical Affairs definitely there is some room for for you with us and all the people that have any background in this as well as engineering business anything that you do with passion uh in which you believe we'll
have uh something with us so please send your CVS to us and we will be more than happy if there is a Connection to take the discussion further thank you everyone for coming we're going to stop now and go to the cocktail downstairs so I invite you all to go downstairs and join us other people from the Macky team and from Cooper SW my team will be there as well uh thank you very much for coming if we can give all a warm word of Applause to our speakers thank you again for ash organization and
uh God bless you guys And believe in yourself and have fun [Applause]